Diasorin Inc.: Medical Device Recalls in 2021

Updated on March 25, 2026.

According to to data from the FDA, there was 1 medical device recall made by Diasorin Inc. in 2021. See the detail of the recall below.

You can see similar recalls for other firms.

Data Source: FDA.

See this for other years:

LIAISON 1-84 PTH Assay - Product Usage: is an in vitro chemiluminescent immunoassay (CLIA) intended for the quantitative determination of parathyroid hormone (1-84) in human serum and EDTA plasma. Measurements of parathyroid hormone levels are used in the differential diagnosis of hypercalcemia and hypocalcemia resulting from disorders of calcium metabolism. The test has to be performed on the LIAISON¿ Analyzer family.